img

Global In-Vitro Diagnostics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In-Vitro Diagnostics Market Insights, Forecast to 2034

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
Market Analysis and InsightsGlobal In-Vitro Diagnostics Market
Global In-Vitro Diagnostics market is expected to reach to US$ 97070 million in 2023, with a positive growth of %, compared with US$ 105140 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, In-Vitro Diagnostics industry is evaluated to reach US$ 130080 million in 2033. The CAGR will be 5.0% during 2023 to 2033.
The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.
Report Covers
This report presents an overview of global In-Vitro Diagnostics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global In-Vitro Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other

Segment by Application


Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, In-Vitro Diagnostics introduction, etc. In-Vitro Diagnostics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of In-Vitro Diagnostics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostics Market Perspective (2018-2033)
2.2 Global In-Vitro Diagnostics Growth Trends by Region
2.2.1 In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In-Vitro Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 In-Vitro Diagnostics Market Dynamics
2.3.1 In-Vitro Diagnostics Industry Trends
2.3.2 In-Vitro Diagnostics Market Drivers
2.3.3 In-Vitro Diagnostics Market Challenges
2.3.4 In-Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In-Vitro Diagnostics by Players
3.1.1 Global In-Vitro Diagnostics Revenue by Players (2018-2023)
3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In-Vitro Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global In-Vitro Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2022
3.5 Global Key Players of In-Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of In-Vitro Diagnostics, Product and Application
3.7 Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033)
5 In-Vitro Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In-Vitro Diagnostics Market Size (2018-2033)
6.2 North America In-Vitro Diagnostics Market Size by Type
6.2.1 North America In-Vitro Diagnostics Market Size by Type (2018-2023)
6.2.2 North America In-Vitro Diagnostics Market Size by Type (2024-2033)
6.2.3 North America In-Vitro Diagnostics Market Share by Type (2018-2033)
6.3 North America In-Vitro Diagnostics Market Size by Application
6.3.1 North America In-Vitro Diagnostics Market Size by Application (2018-2023)
6.3.2 North America In-Vitro Diagnostics Market Size by Application (2024-2033)
6.3.3 North America In-Vitro Diagnostics Market Share by Application (2018-2033)
6.4 North America In-Vitro Diagnostics Market Size by Country
6.4.1 North America In-Vitro Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America In-Vitro Diagnostics Market Size by Country (2018-2023)
6.4.3 North America In-Vitro Diagnostics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe In-Vitro Diagnostics Market Size (2018-2033)
7.2 Europe In-Vitro Diagnostics Market Size by Type
7.2.1 Europe In-Vitro Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe In-Vitro Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe In-Vitro Diagnostics Market Share by Type (2018-2033)
7.3 Europe In-Vitro Diagnostics Market Size by Application
7.3.1 Europe In-Vitro Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe In-Vitro Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe In-Vitro Diagnostics Market Share by Application (2018-2033)
7.4 Europe In-Vitro Diagnostics Market Size by Country
7.4.1 Europe In-Vitro Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe In-Vitro Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe In-Vitro Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In-Vitro Diagnostics Market Size (2018-2033)
8.2 China In-Vitro Diagnostics Market Size by Type
8.2.1 China In-Vitro Diagnostics Market Size by Type (2018-2023)
8.2.2 China In-Vitro Diagnostics Market Size by Type (2024-2033)
8.2.3 China In-Vitro Diagnostics Market Share by Type (2018-2033)
8.3 China In-Vitro Diagnostics Market Size by Application
8.3.1 China In-Vitro Diagnostics Market Size by Application (2018-2023)
8.3.2 China In-Vitro Diagnostics Market Size by Application (2024-2033)
8.3.3 China In-Vitro Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia In-Vitro Diagnostics Market Size (2018-2033)
9.2 Asia In-Vitro Diagnostics Market Size by Type
9.2.1 Asia In-Vitro Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia In-Vitro Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia In-Vitro Diagnostics Market Share by Type (2018-2033)
9.3 Asia In-Vitro Diagnostics Market Size by Application
9.3.1 Asia In-Vitro Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia In-Vitro Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia In-Vitro Diagnostics Market Share by Application (2018-2033)
9.4 Asia In-Vitro Diagnostics Market Size by Region
9.4.1 Asia In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia In-Vitro Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia In-Vitro Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche In-Vitro Diagnostics Introduction
11.1.4 Roche Revenue in In-Vitro Diagnostics Business (2018-2023)
11.1.5 Roche Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott In-Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in In-Vitro Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Developments
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher In-Vitro Diagnostics Introduction
11.3.4 Danaher Revenue in In-Vitro Diagnostics Business (2018-2023)
11.3.5 Danaher Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers In-Vitro Diagnostics Introduction
11.4.4 Siemens Healthineers Revenue in In-Vitro Diagnostics Business (2018-2023)
11.4.5 Siemens Healthineers Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostics Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex In-Vitro Diagnostics Introduction
11.6.4 Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023)
11.6.5 Sysmex Recent Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux In-Vitro Diagnostics Introduction
11.7.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023)
11.7.5 BioMerieux Recent Developments
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Details
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023)
11.8.5 Ortho Clinical Diagnostics Recent Developments
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Details
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson In-Vitro Diagnostics Introduction
11.9.4 Becton Dickinson Revenue in In-Vitro Diagnostics Business (2018-2023)
11.9.5 Becton Dickinson Recent Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in In-Vitro Diagnostics Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Developments
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic In-Vitro Diagnostics Introduction
11.11.4 Hologic Revenue in In-Vitro Diagnostics Business (2018-2023)
11.11.5 Hologic Recent Developments
11.12 LifeScan
11.12.1 LifeScan Company Details
11.12.2 LifeScan Business Overview
11.12.3 LifeScan In-Vitro Diagnostics Introduction
11.12.4 LifeScan Revenue in In-Vitro Diagnostics Business (2018-2023)
11.12.5 LifeScan Recent Developments
11.13 Qiagen
11.13.1 Qiagen Company Details
11.13.2 Qiagen Business Overview
11.13.3 Qiagen In-Vitro Diagnostics Introduction
11.13.4 Qiagen Revenue in In-Vitro Diagnostics Business (2018-2023)
11.13.5 Qiagen Recent Developments
11.14 Wuhan Easy Diagnosis
11.14.1 Wuhan Easy Diagnosis Company Details
11.14.2 Wuhan Easy Diagnosis Business Overview
11.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Introduction
11.14.4 Wuhan Easy Diagnosis Revenue in In-Vitro Diagnostics Business (2018-2023)
11.14.5 Wuhan Easy Diagnosis Recent Developments
11.15 Wondfo
11.15.1 Wondfo Company Details
11.15.2 Wondfo Business Overview
11.15.3 Wondfo In-Vitro Diagnostics Introduction
11.15.4 Wondfo Revenue in In-Vitro Diagnostics Business (2018-2023)
11.15.5 Wondfo Recent Developments
11.16 KHB
11.16.1 KHB Company Details
11.16.2 KHB Business Overview
11.16.3 KHB In-Vitro Diagnostics Introduction
11.16.4 KHB Revenue in In-Vitro Diagnostics Business (2018-2023)
11.16.5 KHB Recent Developments
11.17 Hotgen
11.17.1 Hotgen Company Details
11.17.2 Hotgen Business Overview
11.17.3 Hotgen In-Vitro Diagnostics Introduction
11.17.4 Hotgen Revenue in In-Vitro Diagnostics Business (2018-2023)
11.17.5 Hotgen Recent Developments
11.18 Mindray
11.18.1 Mindray Company Details
11.18.2 Mindray Business Overview
11.18.3 Mindray In-Vitro Diagnostics Introduction
11.18.4 Mindray Revenue in In-Vitro Diagnostics Business (2018-2023)
11.18.5 Mindray Recent Developments
11.19 Sinocare
11.19.1 Sinocare Company Details
11.19.2 Sinocare Business Overview
11.19.3 Sinocare In-Vitro Diagnostics Introduction
11.19.4 Sinocare Revenue in In-Vitro Diagnostics Business (2018-2023)
11.19.5 Sinocare Recent Developments
11.20 Getein Biotech
11.20.1 Getein Biotech Company Details
11.20.2 Getein Biotech Business Overview
11.20.3 Getein Biotech In-Vitro Diagnostics Introduction
11.20.4 Getein Biotech Revenue in In-Vitro Diagnostics Business (2018-2023)
11.20.5 Getein Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Tissue Diagnostics
Table 3. Key Players of Professional Diagnostic
Table 4. Key Players of Molecular Diagnostic
Table 5. Key Players of Diabetes Monitoring
Table 6. Key Players of Other
Table 7. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global In-Vitro Diagnostics Market Share by Region (2018-2023)
Table 11. Global In-Vitro Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global In-Vitro Diagnostics Market Share by Region (2024-2033)
Table 13. In-Vitro Diagnostics Market Trends
Table 14. In-Vitro Diagnostics Market Drivers
Table 15. In-Vitro Diagnostics Market Challenges
Table 16. In-Vitro Diagnostics Market Restraints
Table 17. Global In-Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global In-Vitro Diagnostics Revenue Share by Players (2018-2023)
Table 19. Global Top In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)
Table 20. Global In-Vitro Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by In-Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of In-Vitro Diagnostics, Headquarters and Area Served
Table 23. Global Key Players of In-Vitro Diagnostics, Product and Application
Table 24. Global Key Players of In-Vitro Diagnostics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global In-Vitro Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global In-Vitro Diagnostics Revenue Share by Application (2018-2023)
Table 32. Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global In-Vitro Diagnostics Revenue Share by Application (2024-2033)
Table 34. North America In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 48. China In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 50. China In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia In-Vitro Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia In-Vitro Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche In-Vitro Diagnostics Product
Table 69. Roche Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott In-Vitro Diagnostics Product
Table 74. Abbott Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Abbott Recent Developments
Table 76. Danaher Company Details
Table 77. Danaher Business Overview
Table 78. Danaher In-Vitro Diagnostics Product
Table 79. Danaher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Danaher Recent Developments
Table 81. Siemens Healthineers Company Details
Table 82. Siemens Healthineers Business Overview
Table 83. Siemens Healthineers In-Vitro Diagnostics Product
Table 84. Siemens Healthineers Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 85. Siemens Healthineers Recent Developments
Table 86. Thermo Fisher Scientific Company Details
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific In-Vitro Diagnostics Product
Table 89. Thermo Fisher Scientific Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 90. Thermo Fisher Scientific Recent Developments
Table 91. Sysmex Company Details
Table 92. Sysmex Business Overview
Table 93. Sysmex In-Vitro Diagnostics Product
Table 94. Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Sysmex Recent Developments
Table 96. BioMerieux Company Details
Table 97. BioMerieux Business Overview
Table 98. BioMerieux In-Vitro Diagnostics Product
Table 99. BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 100. BioMerieux Recent Developments
Table 101. Ortho Clinical Diagnostics Company Details
Table 102. Ortho Clinical Diagnostics Business Overview
Table 103. Ortho Clinical Diagnostics In-Vitro Diagnostics Product
Table 104. Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 105. Ortho Clinical Diagnostics Recent Developments
Table 106. Becton Dickinson Company Details
Table 107. Becton Dickinson Business Overview
Table 108. Becton Dickinson In-Vitro Diagnostics Product
Table 109. Becton Dickinson Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 110. Becton Dickinson Recent Developments
Table 111. Bio-Rad Laboratories Company Details
Table 112. Bio-Rad Laboratories Business Overview
Table 113. Bio-Rad Laboratories In-Vitro Diagnostics Product
Table 114. Bio-Rad Laboratories Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 115. Bio-Rad Laboratories Recent Developments
Table 116. Hologic Company Details
Table 117. Hologic Business Overview
Table 118. Hologic In-Vitro Diagnostics Product
Table 119. Hologic Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 120. Hologic Recent Developments
Table 121. LifeScan Company Details
Table 122. LifeScan Business Overview
Table 123. LifeScan In-Vitro Diagnostics Product
Table 124. LifeScan Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 125. LifeScan Recent Developments
Table 126. Qiagen Company Details
Table 127. Qiagen Business Overview
Table 128. Qiagen In-Vitro Diagnostics Product
Table 129. Qiagen Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 130. Qiagen Recent Developments
Table 131. Wuhan Easy Diagnosis Company Details
Table 132. Wuhan Easy Diagnosis Business Overview
Table 133. Wuhan Easy Diagnosis In-Vitro Diagnostics Product
Table 134. Wuhan Easy Diagnosis Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 135. Wuhan Easy Diagnosis Recent Developments
Table 136. Wondfo Company Details
Table 137. Wondfo Business Overview
Table 138. Wondfo In-Vitro Diagnostics Product
Table 139. Wondfo Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 140. Wondfo Recent Developments
Table 141. KHB Company Details
Table 142. KHB Business Overview
Table 143. KHB In-Vitro Diagnostics Product
Table 144. KHB Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 145. KHB Recent Developments
Table 146. Hotgen Company Details
Table 147. Hotgen Business Overview
Table 148. Hotgen In-Vitro Diagnostics Product
Table 149. Hotgen Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 150. Hotgen Recent Developments
Table 151. Mindray Company Details
Table 152. Mindray Business Overview
Table 153. Mindray In-Vitro Diagnostics Product
Table 154. Mindray Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 155. Mindray Recent Developments
Table 156. Sinocare Company Details
Table 157. Sinocare Business Overview
Table 158. Sinocare In-Vitro Diagnostics Product
Table 159. Sinocare Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 160. Sinocare Recent Developments
Table 161. Getein Biotech Company Details
Table 162. Getein Biotech Business Overview
Table 163. Getein Biotech In-Vitro Diagnostics Product
Table 164. Getein Biotech Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 165. Getein Biotech Recent Developments
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global In-Vitro Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Tissue Diagnostics Features
Figure 4. Professional Diagnostic Features
Figure 5. Molecular Diagnostic Features
Figure 6. Diabetes Monitoring Features
Figure 7. Other Features
Figure 8. Global In-Vitro Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global In-Vitro Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Diabetes Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Oncology Case Studies
Figure 13. Cardiology Case Studies
Figure 14. HIV Case Studies
Figure 15. Other Case Studies
Figure 16. In-Vitro Diagnostics Report Years Considered
Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2022 VS 2033
Figure 20. Global In-Vitro Diagnostics Market Share by Players in 2022
Figure 21. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by In-Vitro Diagnostics Revenue in 2022
Figure 23. North America In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 25. North America In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 26. North America In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 27. United States In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Canada In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 30. Europe In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 31. Europe In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 32. Europe In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 33. Germany In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. France In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. U.K. In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Italy In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Russia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Nordic Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. China In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 40. China In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 41. China In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 42. Asia In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 43. Asia In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 44. Asia In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 45. Asia In-Vitro Diagnostics Market Share by Region (2018-2033)
Figure 46. Japan In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. South Korea In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. China Taiwan In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Southeast Asia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. India In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Australia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 54. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 55. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 56. Brazil In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Mexico In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Turkey In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Saudi Arabia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Israel In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. GCC Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 63. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 64. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 65. Siemens Healthineers Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 67. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 68. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 69. Ortho Clinical Diagnostics Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 70. Becton Dickinson Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 72. Hologic Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 73. LifeScan Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 74. Qiagen Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 75. Wuhan Easy Diagnosis Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 76. Wondfo Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 77. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 78. Hotgen Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 79. Mindray Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 80. Sinocare Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 81. Getein Biotech Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed